Brief: Inozyme Pharma Presents Preclinical Data Suggesting Utility Of INZ-701
07/05/2021 12:46
May 7 (Reuters) - Inozyme Pharma Inc INZY.O :
* INOZYME PHARMA PRESENTS PRECLINICAL DATA SUGGESTING
UTILITY OF
INZ-701 AS A POTENTIAL TREATMENT FOR ABCC6 DEFICIENCY
Source text for Eikon: ID:nGNXbSzSCR
Further company coverage: INZY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inozyme Pharma
See all newsBrief: Inozyme Pharma postpones 2025 annual meeting of stockholders
U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma
U.S. STOCKS ON THE MOVE-Netflix, Acadia Pharma, CoreWeave
U.S. STOCKS ON THE MOVE-Inozyme Pharma, Emerson Electric, Stanley Black & Decker
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin